As part of the university's commitment to economic development and outreach, CTL hosts a variety of events to create connections between the Cornell campuses, industry members, entrepreneurs, and investors.
Inventions Roundtable™ - Metabolic Disease Technologies
October 28, 2013
Open to: Invite only.
This event featured presentations on emerging technologies related to metabolic diseases. Invited guests provided feedback in the areas of marketability and applications.
- Method to Identify Circulating Factor that Controls Insulin Sensitivity/Secretion
- CD36 Inhibition to Control Obesity and Insulin Sensitivity
- MICAL2-A Novel Therapeutic Target for Metastasis, Diabetes, and Other Diseases of SRF Signaling
- Improving pancreatic beta-cell function (with RAR-beta antagonists)
To view photos from this event click here.